Intellectus Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Intellectus Partners’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.39M	Buy	2,650 +617	+30%	+$324K	0.3%	94
2025 Q1	$1.29M	Buy	2,033 +978	+93%	+$620K	0.32%	93
2024 Q4	$752K	Hold	1,055	–	–	0.17%	158
2024 Q3	$1.11M	Hold	1,055	–	–	0.28%	105
2024 Q2	$1.11M	Sell	1,055 -100	-9%	-$105K	0.3%	90
2024 Q1	$1.11M	Sell	1,155 -125	-10%	-$120K	0.29%	101
2023 Q4	$1.12M	Hold	1,280	–	–	0.32%	85
2023 Q3	$1.05M	Sell	1,280 -397	-24%	-$327K	0.33%	87
2023 Q2	$1.2M	Sell	1,677 -200	-11%	-$144K	0.36%	79
2023 Q1	$1.54M	Buy	1,877 +22	+1%	+$18.1K	0.49%	60
2022 Q4	$1.34M	Sell	1,855 -42	-2%	-$30.3K	0.47%	60
2022 Q3	$1.31M	Sell	1,897 -88	-4%	-$60.6K	0.46%	60
2022 Q2	$1.17M	Hold	1,985	–	–	0.4%	72
2022 Q1	$1.39M	Sell	1,985 -175	-8%	-$122K	0.41%	64
2021 Q4	$1.36M	Sell	2,160 -550	-20%	-$347K	0.35%	76
2021 Q3	$1.64M	Buy	2,710 +215	+9%	+$130K	0.4%	66
2021 Q2	$1.39M	Buy	2,495 +30	+1%	+$16.8K	0.31%	81
2021 Q1	$1.17M	Sell	2,465 -815	-25%	-$386K	0.32%	90
2020 Q4	$1.59M	Buy	3,280 +1,028	+46%	+$497K	0.47%	61
2020 Q3	$1.26M	Buy	2,252 +778	+53%	+$436K	0.48%	56
2020 Q2	$919K	Buy	1,474 +41	+3%	+$25.6K	0.36%	81
2020 Q1	$700K	Sell	1,433 -3,245	-69%	-$1.59M	0.33%	88
2019 Q4	$1.76M	Buy	4,678 +947	+25%	+$355K	0.71%	36
2019 Q3	$1.04M	Buy	3,731 +933	+33%	+$259K	0.45%	59
2019 Q2	$876K	Buy	2,798 +462	+20%	+$145K	0.38%	79
2019 Q1	$959K	Sell	2,336 -141	-6%	-$57.9K	0.41%	68
2018 Q4	$925K	Buy	2,477 +1,128	+84%	+$421K	0.63%	41
2018 Q3	$545K	Sell	1,349 -895	-40%	-$362K	0.19%	132
2018 Q2	$774K	Buy	2,244 +929	+71%	+$320K	0.28%	101
2018 Q1	$453K	Sell	1,315 -108	-8%	-$37.2K	0.16%	147
2017 Q4	$535K	Hold	1,423	–	–	0.2%	127
2017 Q3	$636K	Sell	1,423 -326	-19%	-$146K	0.26%	93
2017 Q2	$859K	Buy	1,749 +93	+6%	+$45.7K	0.39%	67
2017 Q1	$642K	Buy	1,656 +29	+2%	+$11.2K	0.33%	82
2016 Q4	$597K	Buy	+1,627	New	+$597K	0.31%	87